Analyst Ratings for Trevi Therapeutics (TRVI)
TRVI Rating Summary
TRVI Price Target Summary
- Highest: $40.00 (Clear Street)
- Lowest: $20.00 (Morgan Stanley)
- Average: $26.60
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$26.60 (+46.8%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$26.60 (+46.8%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/20/2026 | BMO Capital | Connor Murphy | New Coverage | Outperform (N/A) |
N/A (N/A) |
19.07 (18.12) |
-4.98% | Details |
| 11/13/2025 | Leerink » Updated 4/21/2026 |
Roanna Ruiz | New Coverage | Outperform (N/A) |
25.00 (21.00) |
11.85 (18.12) |
52.91% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
